Clinical Trial Update: MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for MTX110 delivered via convection-enhanced delivery in newly diagnosed diffuse intrinsic pontine glioma has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• MTX110 (methotrexate)

Snippet

Sponsor: Sabine Mueller, MD, PhD | Conditions: Diffuse Intrinsic Pontine Glioma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-02-25